Rare diseases
Investigational molecules
Locations
Back to Bulgaria61 clinical trials in Lovech, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa
BulgariaA study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa
BulgariaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
BulgariaA Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress
BulgariaLong-Term Safety Study of Direclidine in Adults with Schizophrenia
BulgariaA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
BulgariaA study testing direclidine compared to placebo in adults with schizophrenia who need hospital care
BulgariaA Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress
BulgariaTesting WIN378 Safety and Effects in Adults with Moderate or Severe Asthma
BulgariaStudy of felzartamab compared to placebo in adults with IgA nephropathy
BulgariaStudy on ITI-1284 for Treating Agitation in Alzheimer's Patients
BulgariaTesting GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on respiratory viral infections and chronic conditions, including studies of RSV, hMPV, and influenza vaccines for older adults.
Multiple trials investigating innovative treatments for both acute and chronic respiratory conditions.
Comprehensive studies examining treatments for various inflammatory skin disorders, from chronic urticaria to severe psoriasis.
Advanced therapeutic approaches targeting specific dermatological pathways.
Innovative research in psychiatric disorders and heart conditions, exploring new treatment modalities.
Focus on both emergency interventions and long-term therapeutic solutions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
